Codiak Biosciences competitorsClear all

Nimbus Therapeutics's top competitors include Takeda Pharmaceutical, AstraZeneca and ArunA Bio.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Nimbus Therapeutics
Nimbus Therapeutics
Nimbus Therapeutics is a biotechnology company which operates an application of computational chemistry to design treatments for substantial and underserved human diseases.
Takeda Pharmaceutical
Takeda Pharmaceutical
Takeda Pharmaceutical is a biopharmaceutical company.
AstraZeneca
AstraZeneca
AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
ArunA Bio
ArunA Bio
ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.
Founding Date
Founding Date
2009
Founding Date
1781
Founding Date
1999
Founding Date
2003
Type
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Locations
Tokyo, JP HQ
The Rocks, AU
Linz, AT
Wien, AT
Sint Jans Molenbeek, BE
Santo Amaro, BR
Toronto, CA
see more
Locations
Cambridge, GB HQ
Alger, DZ
Buenos Aires, AR
Haedo, AR
Macquarie Park, AU
Macquarie Park, AU
North Ryde, AU
see more
Locations
Athens, US HQ
Athens, US
Employees
Employees
678% increase
Employees
47,4954% decrease
Employees
76,1008% increase
Employees
274% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
44.9 b
Valuation ($)
166 b
Valuation ($)
N/A
Twitter followers
Twitter followers
1.2 k
Twitter followers
N/A
Twitter followers
295.6 k
Twitter followers
222
Number of tweets (last 30 days)
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
85
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
8.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
31.8
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
92.94%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
294954
Alexa Website Rank
157946
Alexa Website Rank
103435
Alexa Website Rank
236972
Employee Rating
Employee Rating
4.5
Employee Rating
3.9
Employee Rating
4.2
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥3.3t (FY, 2020)
Revenue (est.)
$24.4b (FY, 2019)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
¥1.1t (FY, 2020)
Cost of goods
$4.9b (FY, 2019)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
¥2.2t (FY, 2020)
Gross profit
$19.5b (FY, 2019)
Gross profit
N/A
Net income
Net income
N/A
Net income
¥44.3b (FY, 2020)
Net income
$1.2b (FY, 2019)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 105m (5 months ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 4.5m (about 2 years ago)
Total funding raised
Total funding raised
$ 242m
Total funding raised
$ 57.8m
Total funding raised
$ 1b
Total funding raised
$ 26.9m
For sources of this data, please see the company profile

View company profiles

Takeda Pharmaceutical
HQ
Tokyo, JP
Employees
47,495↓ 4% decrease

Takeda Pharmaceutical is a biopharmaceutical company.

View company
AstraZeneca
HQ
Cambridge, GB
Employees
76,100↑ 8% increase

AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.

View company
ArunA Bio
HQ
Athens, US
Employees
27↑ 4% increase

ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.

View company